Short answer
IRONWOOD PHARMACEUTICALS INC (IRWD) filed an 8-K current report with the SEC on March 11, 2026 reporting Item 8.01 (Other Events). Ironwood confirmed it met liquidity conditions required to lock in the Dec 31, 2028 maturity date on its revolving credit facility.
IRONWOOD PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Ironwood confirmed it met liquidity conditions required to lock in the Dec 31, 2028 maturity date on its revolving credit facility
- Failure to satisfy these conditions would have triggered an earlier maturity: confirmation removes that near-term refinancing risk
- Credit facility originally dated May 2023, amended Sept 2024; Wells Fargo serves as administrative agent
- Positive signal for balance sheet stability heading into 2026, reducing credit/liquidity overhang for investors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IRONWOOD PHARMACEUTICALS INC 8-K filings
Get the next IRWD 8-K as it lands
Follow IRWD for push alerts, or ask the research agent what this filing means.